Publication
January 25, 2018

The recent decision in Sandra Bailey & Others v GlaxoSmithKline UK Ltd represents an important development in the law concerning the liability of third party funders for opponents’ costs. In addition to affecting funders themselves, the decision is relevant to parties involved in funded litigation befor the English Courts, or involved in funded LCIA or ICC arbitrations.  It is also relevant to those providing or purchasing Afer The Event insurance.

Read more.